Form EFFECT Nasus Pharma Ltd
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 20, 2026 |
| Accession Number: | 0001493152-26-039052 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nasus Pharma CFO departs, interim replacement named
- Nasus Pharma Announces Transition of Chief Financial Officer
- Luma Hydrogen Launches with 400 km² Geologic Hydrogen Land Position in Atlantic Canada and Commences Summer 2026 Exploration Program
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
